Palo Alto Investors

Palo Alto Investors as of June 30, 2022

Portfolio Holdings for Palo Alto Investors

Palo Alto Investors holds 33 positions in its portfolio as reported in the June 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
BioMarin Pharmaceutical (BMRN) 14.9 $171M 2.1M 82.87
United Therapeutics Corporation (UTHR) 13.0 $150M 635k 235.64
Abiomed 10.7 $122M 494k 247.51
Insmed (INSM) 10.0 $115M 5.8M 19.72
Amicus Therapeutics (FOLD) 9.2 $106M 9.8M 10.74
STAAR Surgical Company (STAA) 6.8 $79M 1.1M 70.93
Biogen Idec (BIIB) 6.4 $74M 361k 203.94
Revance Therapeutics (RVNC) 5.3 $61M 4.4M 13.82
Prothena (PRTA) 4.0 $46M 1.7M 27.15
Sage Therapeutics (SAGE) 2.4 $28M 851k 32.30
Vanda Pharmaceuticals (VNDA) 2.4 $27M 2.5M 10.90
Karyopharm Therapeutics (KPTI) 2.2 $25M 5.6M 4.51
ACADIA Pharmaceuticals (ACAD) 2.1 $24M 1.7M 14.09
Alkermes (ALKS) 1.6 $18M 603k 29.79
eHealth (EHTH) 1.3 $15M 1.7M 9.33
Gossamer Bio (GOSS) 1.3 $15M 1.8M 8.37
Syndax Pharmaceuticals (SNDX) 1.0 $12M 613k 19.24
Align Technology (ALGN) 0.9 $11M 44k 236.68
Epizyme 0.9 $10M 6.8M 1.47
Anaptysbio Inc Common (ANAB) 0.8 $8.8M 431k 20.30
Clovis Oncology 0.7 $8.1M 4.5M 1.80
Gritstone Oncology Ord (GRTS) 0.5 $5.6M 2.3M 2.42
Kezar Life Sciences (KZR) 0.5 $5.4M 656k 8.27
Cytokinetics (CYTK) 0.4 $4.4M 112k 39.29
Travere Therapeutics (TVTX) 0.4 $4.0M 166k 24.23
Mirum Pharmaceuticals (MIRM) 0.1 $1.3M 65k 19.46
Alimera Sciences 0.1 $1.1M 201k 5.47
Novavax (NVAX) 0.1 $643k 13k 51.44
Aldeyra Therapeutics (ALDX) 0.1 $642k 161k 3.99
Magenta Therapeutics 0.0 $519k 432k 1.20
Urogen Pharma (URGN) 0.0 $201k 25k 8.20
Tactile Systems Technology, In (TCMD) 0.0 $198k 27k 7.31
Marinus Pharmaceuticals (MRNS) 0.0 $152k 31k 4.85